JPY 800.0
(-0.25%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | 642.13 Million | 446.03 Million | 403.23 Million | 621.83 Million | 294 Million |
Net Income | 615.98 Million | 316.76 Million | 458.52 Million | 218.98 Million | 267 Million |
Depreciation & Amortization | 147.61 Million | 44.16 Million | 23.08 Million | 21.09 Million | 37 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | 20.57 Million | 17.84 Million | 10.11 Million | - | - |
Change in working capital | 158.18 Million | 63.75 Million | -33.4 Million | 406.89 Million | 44 Million |
Other non-cash items | -7.06 Million | 154.54 Million | -12.46 Million | -2.94 Million | -54 Million |
Investing Cash Flow | -13.22 Million | -431.17 Million | -15.77 Million | 23.73 Million | -607 Million |
Investments in PPE | -104.14 Million | -11.62 Million | -15.77 Million | -14.97 Million | -102 Million |
Acquisitions | - | - | - | - | - |
Investment purchases | -99.9 Million | -299.94 Million | - | - | -306.05 Million |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | 190.81 Million | -119.6 Million | -15 Million | 38.7 Million | -190.82 Million |
Financing Cash Flow | -143.89 Million | -61.26 Million | -136.86 Million | -134.03 Million | -115 Million |
Debt repayment | -15.69 Million | -75 Million | -5.76 Million | -5.74 Million | -955 Thousand |
Dividends payments | -139.48 Million | -131.06 Million | -131.09 Million | -128.21 Million | -114.37 Million |
Common Stock Repurchased | - | -74.92 Million | - | -73 Thousand | - |
Common Stock Issuance | 15.84 Million | 75.02 Million | - | - | - |
Other Financing Activities | -4.56 Million | 70 Million | -1000.00 | -1000.00 | -1000.00 |
Accounts receivables | 42.62 Million | 38 Million | -30 Million | 180 Million | 83 Million |
Accounts payables | 19.93 Million | -1.1 Million | 4.91 Million | -9.92 Million | -5.2 Million |
Inventory | - | - | - | - | - |
Other working capital | 95.62 Million | 180 Million | -3 Million | 223 Million | -39 Million |
Cash at beginning of period | 3.58 Billion | 3.71 Billion | 3.46 Billion | 2.94 Billion | 3.37 Billion |
Cash at end of period | 4.14 Billion | 3.66 Billion | 3.71 Billion | 3.46 Billion | -428 Million |
Capital Expenditure | -104.14 Million | -11.62 Million | -15.77 Million | -14.97 Million | -102 Million |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | 568.22 Million | -46.41 Million | 250.59 Million | 511.53 Million | -3.8 Billion |
Free Cash Flow | 537.99 Million | 434.4 Million | 387.46 Million | 606.86 Million | 192 Million |
Breakdown | 2023 FY | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2021 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 615.98 Million | 316.76 Million | -58 Thousand | 89 Thousand | 120 Thousand | 458.52 Million |
Depreciation & Amortization | 147.61 Million | 44.16 Million | - | - | - | 23.08 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 20.57 Million | 17.84 Million | - | - | - | 10.11 Million |
Change in working capital | 158.18 Million | 63.75 Million | - | - | - | -33.4 Million |
Other non-cash items | -7.06 Million | 154.54 Million | 58 Thousand | -89 Thousand | -120 Thousand | -12.46 Million |
Investing Cash Flow | -13.22 Million | -431.17 Million | - | - | - | -15.77 Million |
Investments in PPE | -104.14 Million | -11.62 Million | - | - | - | -15.77 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -99.9 Million | -299.94 Million | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 190.81 Million | -119.6 Million | - | - | - | -15 Million |
Financing Cash Flow | -143.89 Million | -61.26 Million | - | - | - | -136.86 Million |
Debt repayment | -15.69 Million | -75 Million | - | - | - | -5.76 Million |
Dividends payments | -139.48 Million | -131.06 Million | - | - | - | -131.09 Million |
Common Stock Repurchased | - | -74.92 Million | - | - | - | - |
Common Stock Issuance | 15.84 Million | 75.02 Million | - | - | - | - |
Other Financing Activities | - | 70 Million | - | - | - | -1000.00 |
Accounts receivables | 42.62 Million | 38 Million | - | - | - | -30 Million |
Accounts payables | 19.93 Million | -1.1 Million | - | - | - | 4.91 Million |
Inventory | - | - | - | - | - | - |
Other working capital | 95.62 Million | 180 Million | - | - | - | -3 Million |
Cash at beginning of period | 3.58 Billion | 3.71 Billion | - | - | - | 3.46 Billion |
Cash at end of period | 4.14 Billion | 3.66 Billion | - | - | - | 3.71 Billion |
Capital Expenditure | -104.14 Million | -11.62 Million | - | - | - | -15.77 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 568.22 Million | -46.41 Million | - | - | - | 250.59 Million |
Free Cash Flow | 537.99 Million | 434.4 Million | - | - | - | 387.46 Million |
DISI
SRSCQ
ARCVF
3521
GZPZY
CVS